OSSIO
Bart Overturf currently serves as the National Business Development Manager at OSSIO since September 2024. Prior to this role, Bart was the Regional Sales Director at Artelon and held multiple positions at Smith & Nephew, including Director of Fellowships and Global Societies and Sr. Global Marketing Specialist, among others. Bart's extensive experience also includes leadership in sales roles at Xiros North America and management in the medical device sector at Rocky Mountain Orthopaedics, where Bart was President/Owner. Bart began their career in sales at Sports Medicine and Brace, focusing on orthopaedic products. Bart holds a Bachelor of Science in Marketing from the University of Wyoming, earned in 1991.
This person is not in any teams
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.